Results 141 to 150 of about 149,288 (230)

The Response of Iranian Melon (Cucumis melo L.) Accessions to 2,4-D Drift. [PDF]

open access: yesPlants (Basel), 2021
Zangoueinejad R   +3 more
europepmc   +1 more source

Trans‐Tendon Suture‐Bridge Knotless Proximal Pulley Repair With Bioinductive Patch Augmentation for High‐Grade Partial Hip Abductor Tendon Tears

open access: yesArthroscopy Techniques, EarlyView.
Abstract This technical note describes a knotless trans‐tendon proximal‐pulley repair with distal suture‐bridge fixation and bioinductive collagen patch augmentation for high‐grade partial gluteus medius and minimus tears. The technique preserves intact tendon fibers, restores broad footprint compression, and supports biologic healing through a ...
Maria Agustina Olarán   +6 more
wiley   +1 more source

Production of Indole-3-Acetic Acid and Degradation of 2,4-D by Yeasts Isolated from Pollinating Insects. [PDF]

open access: yesMicroorganisms
Oliveira CG   +8 more
europepmc   +1 more source

Triple Technique for Neglected Locked Patellar Dislocation With Lateral Release, Synthetic Medial Patellofemoral Ligament, and Peroneus Longus Autograft Medial Quadriceps Tendon‐Femoral Ligament Reconstruction

open access: yesArthroscopy Techniques, EarlyView.
Abstract Patellar dislocation is a frequent emergency presentation. First‐time dislocations are associated with medial patellofemoral ligament injury in up to 94.7% of cases. Although many reduce spontaneously, reduction under anesthesia may be required.
Hesham Ahmed Abdul Galil   +3 more
wiley   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Trends in publicly subsidized and private access to GLP‐1 medicines indicated for type 2 diabetes in Australia, 2020–2025

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims GLP‐1 medicines provide substantial cardio‐renal benefits for type 2 diabetes (T2D) and are increasingly used for weight loss. Most high‐income countries subsidize access for T2D with restrictions; use outside of these restrictions occurs through private prescriptions. Despite strong consumer demand, the extent of private access to GLP‐1 medicines
Michael O. Falster   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy